P

Inventor

KOTIAN PRAVIN L

US49 patents
⚠️ This page may combine multiple inventors who share the name “KOTIAN PRAVIN L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BIOCRYST PHARM INC

43 patents
US10329260B2Jun 25, 2019

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC26 citations98
US10125102B2Nov 13, 2018

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC24 citations98
US7560434B2Jul 14, 2009

AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases

BIOCRYST PHARM INC92 citations97
US7514410B2Apr 7, 2009

Hepatitis C therapies

BIOCRYST PHARM INC80 citations97
US6699994B1Mar 2, 2004

Biaryl compounds as serine protease inhibitors

BIOCRYST PHARM INC87 citations97
US10689346B2Jun 23, 2020

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC10 citations92
US10633345B2Apr 28, 2020

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC10 citations92
US6936719B2Aug 30, 2005

Biaryl compounds as serine protease inhibitors

BIOCRYST PHARM INC37 citations92
US11708332B2Jul 25, 2023

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC2 citations84
US11708333B2Jul 25, 2023

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC2 citations84
US11230530B2Jan 25, 2022

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC5 citations84
US11203574B2Dec 21, 2021

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC5 citations84
US11192861B2Dec 7, 2021

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC5 citations84
US10420769B2Sep 24, 2019

Methods and compositions for inhibition of polymerase

BIOCRYST PHARM INC4 citations84
US10022375B2Jul 17, 2018

Methods and compositions for inhibition of polymerase

BIOCRYST PHARM INC5 citations84
US9492452B2Nov 15, 2016

Methods and compositions for inhibition of polymerase

BIOCRYST PHARM INC9 citations84
US6518299B1Feb 11, 2003

Substituted pyrrolidine compounds useful as neuraminidase inhibitors

BIOCRYST PHARM INC13 citations84
US11370774B2Jun 28, 2022

Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

BIOCRYST PHARM INC4 citations83
US11021458B2Jun 1, 2021

Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

BIOCRYST PHARM INC5 citations83
US12162838B2Dec 10, 2024

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC0 citations73
US12116346B2Oct 15, 2024

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC0 citations73
US11685721B2Jun 27, 2023

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC2 citations73
US11559515B2Jan 24, 2023

Indole compounds and analogues thereof

BIOCRYST PHARM INC2 citations73
US11173159B2Nov 16, 2021

Methods and compositions for inhibition of polymerase

BIOCRYST PHARM INC3 citations73
US10849883B2Dec 1, 2020

Benzopyrazole compounds and analogues thereof

BIOCRYST PHARM INC3 citations73
US10562850B2Feb 18, 2020

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC2 citations73
US12043610B2Jul 23, 2024

Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

BIOCRYST PHARM INC1 citations72
US11866418B2Jan 9, 2024

Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

BIOCRYST PHARM INC2 citations72
US11708347B2Jul 25, 2023

Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

BIOCRYST PHARM INC3 citations72
US11661426B2May 30, 2023

Imidazole-containing inhibitors of ALK2 kinase

BIOCRYST PHARM INC2 citations72
US7230119B2Jun 12, 2007

Process for the preparation of substituted pyrrolidine derivatives and intermediates

BIOCRYST PHARM INC2 citations63
US12485109B2Dec 2, 2025

Pyrrolo 12.3-dipyrimidine compounds and analogues thereof

BIOCRYST PHARM INC0 citations62
US12054492B2Aug 6, 2024

Imidazole-containing inhibitors of ALK2 kinase

BIOCRYST PHARM INC0 citations62
US11975003B2May 7, 2024

Methods and compositions for treatment of Zika virus infection

BIOCRYST PHARM INC0 citations62
US11807605B2Nov 7, 2023

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC0 citations62
US11618731B2Apr 4, 2023

Prodrugs of kallikrein inhibitors

BIOCRYST PHARM INC0 citations62
US11066360B2Jul 20, 2021

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC1 citations62
US10933066B2Mar 2, 2021

Methods and compositions for treatment of Zika virus infection

BIOCRYST PHARM INC0 citations62
US10759759B2Sep 1, 2020

Prodrugs of kallikrein inhibitors

BIOCRYST PHARM INC1 citations62
US10512649B2Dec 24, 2019

Methods and compositions for treatment of zika virus infection

BIOCRYST PHARM INC0 citations52
US12552827B2Feb 17, 2026

Synthesis of an antiviral azasugar triphosphate

BIOCRYST PHARM INC0 citations51
US9499554B2Nov 22, 2016

Anti-influenza compositions and methods

BIOCRYST PHARM INC1 citations50
US12558341B2Feb 24, 2026

Oral complement factor D inhibitors

BIOCRYST PHARM INC0 citations48

BABU YARLAGADDA S

3 patents

ISLAND PHARMACEUTICALS LTD

1 patent

KOTIAN PRAVIN L

1 patent

BIOCRYST PHARMACETICALS INC

1 patent